OMS Energy Technologies Inc.
OMSEAbout the company
OMS Energy Technologies Inc., through its subsidiaries, manufactures and sells specialty connectors and pipes, surface wellhead and Christmas trees, premium threading services, and other ancillary services in Saudi Arabia, Singapore, Malaysia, Thailand, Indonesia, Cayman Island, and internationally.
Investment snapshot
Positive
4
BUY / PASS
Neutral / negative
7 / 5
NEUTRAL / FAIL
Median fair value
$17.70
+358.5% vs price
Models with upside
7 / 17
Positive margin of safety
Strongest signal
OMSE undervalued: all 7 models price fair value above $3.86 (median $17.70)
Key risk
7 of 8 flag OMSE's growth — Graham, Lynch, Dreman +4 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | PASS | FAIL | BUY · Rank #32 (Top 1%) | PASS | NEUTRAL | BUY | NEUTRAL | NEUTRAL | FAIL | NEUTRAL | NEUTRAL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | +58.9% | +69.8% | N/A | +52.5% | N/A | N/A | +78.2% | +78.7% | +89.2% | N/A | +88.9% | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-05-01–2026-11-01 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-05-01–2026-11-01 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-07-25 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-05-01–2026-11-01 Latest source filing: 2025-07-25 Score computed: 2026-11-14 |
Where It Passes
- Valuation models100% pass✓ 7▾
OMSE undervalued: all 7 models price fair value above $3.86 (median $17.70)
Graham fair value$9.40✓Graham+58.9% margin vs $3.86Buffett fair value$12.80✓Buffett+69.8% margin vs $3.86Greenblatt fair value$8.13✓Greenblatt+52.5% margin vs $3.86Munger fair value$17.70✓Munger+78.2% margin vs $3.86Pabrai fair value$18.08✓Pabrai+78.7% margin vs $3.86Akre fair value$35.83✓Akre+89.2% margin vs $3.86Ackman fair value$34.80✓Ackman+88.9% margin vs $3.86 - Cash Flow80% pass✓ 10✗ 2▾
8 of 10 pass — Buffett and Piotroski object
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing$37.6M✓LynchPositive and growingOperating Cash Flow$40.5M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=23.75%, ROA=26.28%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)3.7x✓Dreman< 8xP/E or FCF YieldP/E=3.3x, FCF Yield=23.0%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive2/2 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap25.2%✓Ackman>= 4%Price / FCF per Share4.0x✓Ackman<= 25Positive Operating Cash Flow frequency2/2 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$37.6M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+22.97%; #246/4519 (top 5.4%)✓OshaughnessyTop 10% of eligible cross-section - Debt & Leverage75% pass✓ 12✗ 3▾
9 of 12 pass — Graham, Lynch and Marks object
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.06, IC: 210.8x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.06✓Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities5.11✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.06✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.06✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=210.8x, D/EBITDA=N/A (D&A unavailable)✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.06✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.0565; #1047/4210 (top 24.9%)✓AsnessTop 30% of eligible cross-section - Efficiency75% pass✓ 9✗ 2▾
6 of 8 pass — Piotroski and Akre object
Current Ratio5.11✓Graham>= 2.0ROIC (3-5 yr avg)74.8%✓Buffett> 10%ROIC - WACC+64.8%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)100.6%✓Greenblatt> 25%Current Ratio Change YoY1.86 -> 5.11✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY✗PiotroskiImproved YoYCurrent Assets / Current Liabilities5.11✓Dreman> 1.5Return on Invested Capital34.7%✓Munger> 15%ROIC (high and growing)FY2022: ROIC=unavailable; FY2023: ROIC=unavailable; FY2024: ROIC=34.7%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC34.7% (RR=100% x ROIC=34.7%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)1/1 years above 12% (latest 34.7%)✓SleepROIC > 12% in a majority of years
Where It Falls Short
- Growth13% pass✓ 3✗ 10▾
7 of 8 flag OMSE's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency2/2 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth44.5%✓Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 28.8% -> 33.9%, operating margin 20.4% -> 29.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability38% pass✓ 16✗ 19▾
10 of 16 flag OMSE's profitability — Graham, Buffett, Lynch +7 more
Positive EPS (10 years)2/4 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)2/4 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)33.6%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE34.8%✓Lynch> 15%EBIT / Enterprise Value61.0%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=61.0%, ROC=100.6%✓GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets26.28%✓PiotroskiROA > 0ROA Change YoY✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=23.75%, ROA=26.28%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY✗PiotroskiImproved YoYPre-Tax Income / Revenue29.6%✓Dreman>= 8%Net Income / Shareholders' Equity34.8%✓Dreman> 12%Margin of SafetyP/E=3.3x, P/B=1.2x✓PabraiP/B < 1.5 or P/E < 15Return on Equity33.6% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePositive Net Income Frequency2/2 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue29.4%✓Ackman>= 15%Net Income / Shareholders Equity34.8%✓Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 28.8% -> 33.9%, operating margin 20.4% -> 29.4%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+27.35%; #207/6340 (top 3.3%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+40.46%; #932/3702 (top 25.2%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity+34.77%; #366/5226 (top 7.0%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation46% pass✓ 17✗ 11▾
7 of 13 flag OMSE's valuation — Graham, Lynch, Marks +4 more
Price / Book Value per Share1.2x✓Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio1.2x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value61.0%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=61.0%, ROC=100.6%✓GreenblattBoth EY > 10% and ROC > 25%Price / EPS3.3x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)3.7x✓Dreman< 8xValuation ReasonablenessP/E=3.3x✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=3.3x, FCF Yield=23.0%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=3.3x, P/B=1.2x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePrice / FCF per Share4.0x✓Ackman<= 25Price vs. Trailing Low100% of trailing low ($3.86)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+27.35%; #207/6340 (top 3.3%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.7866; #1959/6449 (top 30.4%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS3.3x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.16x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.2426; #1544/5247 (top 29.4%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+22.97%; #246/4519 (top 5.4%)✓OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-14.79%; #3701/6202 (top 59.7%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts50% pass✓ 5✗ 5▾
Split decision: 7 NEUTRAL · 5 FAIL · 3 PASS · 1 BUY
Overall verdict✗GrahamFAIL (3/9)✓BuffettPASS (4/9)✗LynchFAIL (4/7)✓GreenblattRank #32✓PiotroskiPASS (F-Score 4)•DremanNEUTRAL (7/11)✓MungerBUY (3/4)•PabraiNEUTRAL (2/3)•AkreNEUTRAL (4/6)✗MarksFAIL (3/5)•AckmanNEUTRAL (6/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Issued 5.0% of shares last year.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|
| Market Cap | $163.9Mcurrent | -- | -- | -- |
| Revenue | $203.6M | -- | $97.5M | -- |
| Operating Income | $59.9M | -- | $19.9M | -- |
| Net Income | $44.8M | -- | $11.6M | -- |
| EPS (Diluted) | $1.18 | -- | $5291.07 | -- |
| Gross Margin | 33.9% | — | 28.8% | — |
| Operating Margin | 29.4% | — | 20.4% | — |
| ROE | 34.8% | — | 32.4% | — |
| Total Debt | $7.3M↑182% | $2.6M | -- | -- |
| Shareholders' Equity | $128.9M↑67% | $77.0M↑115% | $35.9M↑339% | $8.2M |
| Current Ratio | 5.11↑175% | 1.86 | — | — |
| Debt / Equity | 0.06↑68% | 0.03 | — | — |
| Operating Cash Flow | $40.5M | -- | $29.0M | -- |
| Free Cash Flow | $37.6M | -- | $28.0M | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Machinery
OMSE vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAM RESEARCH CORPLRCX | $282.2B | $225.92 | $23.2B | $7.3B | 58.3% | 0.30 | 35.3% | 2.63 | 3/9 | 5/9 | 5/7 | 1/3 | F-Score 8 | 5/11 |
| CATERPILLAR INCCAT | $274.6B | $600.20 | $67.6B | $8.9B | 41.7% | 1.70 | 16.5% | 1.44 | 2/9 | 5/9 | 4/7 | 1/3 | F-Score 6 | 5/11 |
| DEERE & CODE | $181.6B | $673.54 | $45.7B | $5.0B | 19.4% | 0.53 | 13.7% | — | 2/9 | 6/9 | 4/7 | 0/3 | F-Score 5 | 4/11 |
| Johnson Controls International plcJCI | $84.4B | $139.33 | $23.6B | $3.3B | 25.5% | 0.71 | — | 0.93 | 2/9 | 1/9 | 4/7 | 1/3 | F-Score 6 | 4/11 |
| CUMMINS INCCMI | $61.9B | $452.18 | $33.7B | $3.0B | 23.9% | 0.56 | 12.0% | 1.76 | 2/9 | 4/9 | 3/7 | 1/3 | F-Score 6 | 7/11 |
| ITT INC.ITT | $18.8B | $211.18 | $3.9B | $488.0M | 11.9% | 0.19 | 17.4% | 2.58 | 2/9 | 4/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| REGAL REXNORD CORPRRX | $11.7B | $176.41 | $5.9B | $279.5M | 4.1% | 0.70 | 11.5% | 2.15 | 3/9 | 1/9 | 1/7 | 1/3 | F-Score 6 | 3/11 |
| GRACO INCGGG | $11.6B | $72.42 | $2.2B | $521.8M | 19.7% | 0.00 | 27.9% | 3.15 | 4/9 | 7/9 | 4/7 | 1/3 | F-Score 7 | 5/11 |